Pharmaceuticals, Biotechnology and Life Sciences
Patent allowance follows compelling Phase II data showing Namodenoson resolved all cases of NASH after 12 weeks of treatment, and…
Patent allowance follows compelling Phase II data showing Namodenoson resolved all cases of NASH after 12 weeks of treatment, and…
Interim results of pivotal Phase 2 trial reinforce potential of Lonca to become a key part of the treatment paradigm…
DUBLIN–(BUSINESS WIRE)–The “Global Paracetamol Market 2020-2024” report has been added to ResearchAndMarkets.com’s offering. The paracetamol market is poised to grow…
DUBLIN–(BUSINESS WIRE)–The “Global Paracetamol Market 2020-2024” report has been added to ResearchAndMarkets.com’s offering. The paracetamol market is poised to grow…
Dr. Charles Brenner’s latest research focuses on effect of SARS-CoV-2 infection on cells’ NAD levels LOS ANGELES–(BUSINESS WIRE)–$CDXC #CellularHealth–ChromaDex Corp.…
Dr. Charles Brenner’s latest research focuses on effect of SARS-CoV-2 infection on cells’ NAD levels LOS ANGELES–(BUSINESS WIRE)–$CDXC #CellularHealth–ChromaDex Corp.…
Dr. Charles Brenner’s latest research focuses on effect of SARS-CoV-2 infection on cells’ NAD levels LOS ANGELES–(BUSINESS WIRE)–$CDXC #CellularHealth–ChromaDex Corp.…
DUBLIN–(BUSINESS WIRE)–The “Pharmaceutical Continuous Manufacturing Market Forecast to 2027 – COVID-19 Impact and Global Analysis by Product; Application; End User…
DUBLIN–(BUSINESS WIRE)–The “Pharmaceutical Continuous Manufacturing Market Forecast to 2027 – COVID-19 Impact and Global Analysis by Product; Application; End User…